2,673
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Survival and end-of-life aspects among subjects on long-term noninvasive ventilation

ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon
Article: 1840494 | Received 21 Feb 2020, Accepted 19 Oct 2020, Published online: 05 Nov 2020

References

  • Mokhlesi B, Kryger MH, Grunstein RR. Assessment and management of patients with obesity hypoventilation syndrome. Proc Am Thorac Soc. 2008;5(2):218–9.
  • Budweiser S, Riedl SG, Jörres RA, et al. Mortality and prognostic factors in patients with obesity-hypoventilation syndrome undergoing noninvasive ventilation. J Intern Med. 2007;261(4):375–383.
  • Kleopa KA, Sherman M, Neal B, et al. Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci. 1999;164(1):82–88.
  • Bourke SC, Tomlinson M, Williams TL, et al. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol. 2006;5(2):140–147.
  • Mokhlesi B. Obesity hypoventilation syndrome: a state-of-the-art review. Respir Care. 2010;55(10):134–135.
  • Masa JF, Corral J, Caballero C, et al. Non-invasive ventilation in obesity hypoventilation syndrome without severe obstructive sleep apnoea. Thorax. 2016;71(10):899–906.
  • Murphy PB, Rehal S, Arbane G, et al. Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute COPD exacerbation. JAMA. 2017;317(21):2177.
  • Goldberg A, Leger P, Hill N, et al. Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation—A consensus conference report. Chest. 1999;116(2):521–534.
  • Ergan B, Oczkowski S, Rochwerg B, et al. European respiratory society guidelines on long-term home non-invasive ventilation for management of COPD. Eur Respir J. 2019;54(3):1901003.
  • Mokhlesi B, Masa JF, Brozek JL, et al. Evaluation and management of obesity hypoventilation syndrome. An official American thoracic society clinical practice guideline. Am J Respir Crit Care Med. 2019;200(3):e6–e24.
  • Boyd K, Murray SA. Recognising and managing key transitions in end of life care. BMJ. 2010;341(sep16 2):c4863.
  • Brinkman-Stoppelenburg A, Rietjens JA. van der Heide A. The effects of advance care planning on end-of-life care: A systematic review. Palliat Med. 2014;28(8):1000–1025.
  • Smith M, Wrobel J. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014;9:871–888.
  • Windisch W, Geiseler J, Simon K, et al. German national guideline for treating chronic respiratory failure with invasive and non-invasive ventilation – Revised edition 2017: PART 2. Respiration. 2018;96(2):171–203.
  • Global Initiative for Chronic Obstructive Lung Disease. published in Fontana, WI, USA; [cited 2020 Jun 8] Available from: www.goldcopd.org
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
  • Charlson ME, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–1251.
  • Blankenburg T, Benthin C, Pohl S, et al. Survival of hypercapnic patients with COPD and obesity hypoventilation syndrome treated with high intensity non invasive ventilation in the daily routine care. Open Respir Med J. 2017;11(1):31–40.
  • Sancho J, Martínez D, Bures E, et al. Bulbar impairment score and survival of stable amyotrophic lateral sclerosis patients after noninvasive ventilation initiation. ERJ Open Res. 2018;4(2):00159–02017.
  • King CS, Nathan SD. Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities. Lancet Respir Med. 2017;5(1):72–84.
  • Stineman MG, Xie D, Pan Q, et al. All-cause 1-, 5-, and 10-year mortality in elderly people according to activities of daily living stage. J Am Geriatr Soc. 2012;60(3):485–492.
  • Liu Y, Croft J, Anderson L, et al. The association of chronic obstructive pulmonary disease, disability, engagement in social activities, and mortality among US adults aged 70 years or older, 1994–2006. Int J Chron Obstruct Pulmon Dis. 2014;9:75.
  • Boudestein LCM, Rutten FH, Cramer MJ, et al. The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease. Eur J Heart Fail. 2009;11(12):1182–1188.
  • Mannino DM, Thorn D, Swensen A, et al. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32(4):962–969.
  • Castro-Añón O, LA PDL, De la Fuente Sánchez S, et al. Obesity-hypoventilation syndrome: increased risk of death over sleep apnea syndrome. Atkin SL, ed. PLoS One. 2015;10(2):e0117808.
  • Dreher M, Storre JH, Schmoor C, et al. High-intensity versus low-intensity non-invasive ventilation in patients with stable hypercapnic COPD: a randomised crossover trial. Thorax. 2010;65(4):303–308.
  • Köhnlein T, Windisch W, Köhler D, et al. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. Lancet Respir Med. 2014;2(9):698–705.
  • Priou P, Hamel J-F, Person C, et al. Long-term outcome of noninvasive positive pressure ventilation for obesity hypoventilation syndrome. Chest. 2010;138(1):84–90.
  • Raskin J, Vermeersch K, Everaerts S, et al. Do-not-resuscitate orders as part of advance care planning in patients with COPD. ERJ Open Res. 2018;4(1):00116–02017.
  • Nava S, Sturani C, Hartl S, et al. End-of-life decision-making in respiratory intermediate care units: a European survey. Eur Respir J. 2007;30(1):156–164.
  • Gruneir A, Mor V, Weitzen S, et al. Where people die: a multilevel approach to understanding influences on site of death in America. Med Care Res Rev. 2007;64(4):351–378.
  • Gainza-Miranda D, Sanz-Peces EM, Alonso-Babarro A, et al. Breaking barriers: prospective study of a cohort of advanced chronic obstructive pulmonary disease patients to describe their survival and end-of-life palliative care requirements. J Palliat Med. 2019;22(3):290–296.
  • Borel J-C, Burel B, Tamisier R, et al. Comorbidities and mortality in hypercapnic obese under domiciliary noninvasive ventilation. Ma X-L, ed. PLoS One. 2013;8(1):e52006.